Clinical Trial Update: A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/2 trial of INCB099280 in combination with axitinib in adults with advanced solid tumors was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Axitinib (Axitinib)
• INCB099280 (INCB099280)

Snippet

Sponsor: Incyte Corporation | Conditions: Advanced Solid Tumors | Phase 1, Phase 2 | Status: TERMINATED